Lipid-induced insulin resistance: unravelling the mechanism

Insulin resistance has long been associated with obesity. More than 40 years ago, Randle and colleagues postulated that lipids impaired insulin-stimulated glucose use by muscles through inhibition of glycolysis at key points. However, work over the past two decades has shown that lipid-induced insulin resistance in skeletal muscle stems from defects in insulin-stimulated glucose transport activity. The steatotic liver is also resistant to insulin in terms of inhibition of hepatic glucose production and stimulation of glycogen synthesis. In muscle and liver, the intracellular accumulation of lipids-namely, diacylglycerol-triggers activation of novel protein kinases C with subsequent impairments in insulin signalling. This unifying hypothesis accounts for the mechanism of insulin resistance in obesity, type 2 diabetes, lipodystrophy, and ageing; and the insulin-sensitising effects of thiazolidinediones.

[1]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Shulman,et al.  Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[3]  A. Golay,et al.  Pathways from obesity to diabetes , 2002, International Journal of Obesity.

[4]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[5]  M. Digman,et al.  Mechanism of Diacylglycerol-induced Membrane Targeting and Activation of Protein Kinase Cδ* , 2004, Journal of Biological Chemistry.

[6]  Hitoshi Shimano,et al.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance , 2007, Nature Medicine.

[7]  S. Crooke Progress in antisense technology. , 2004, Annual review of medicine.

[8]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[9]  A. Kotronen,et al.  Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome , 2007, Diabetologia.

[10]  P. Scifo,et al.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.

[11]  Y. Nakagawa,et al.  Age-Related Changes in Intramyocellular Lipid in Humans by in vivo 1H-MR Spectroscopy , 2007, Gerontology.

[12]  L. J. Hardies,et al.  Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  G. Shulman,et al.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. , 2007, The Journal of clinical investigation.

[14]  K. Petersen,et al.  Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. , 2002, American journal of physiology. Endocrinology and metabolism.

[15]  K. Petersen,et al.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.

[16]  Dan R. Littman,et al.  PKC-θ knockout mice are protected from fat-induced insulin resistance , 2004 .

[17]  Simon C Watkins,et al.  Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  K. Gumireddy,et al.  Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. , 2005, Diabetes.

[19]  H. Lodish,et al.  Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.

[20]  F. Schick,et al.  Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene , 2009, Diabetes.

[21]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[22]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[23]  A. Diehl,et al.  Nonalcoholic fatty liver disease as a complication of insulin resistance. , 2007, The Medical clinics of North America.

[24]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[25]  D. Cooper,et al.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance , 1998, The Lancet.

[26]  C. Kahn,et al.  Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. , 1988, The Journal of biological chemistry.

[27]  R. Ahima,et al.  Inhibition of ADRP prevents diet-induced insulin resistance. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[28]  Jennifer L. Pomeranz,et al.  A crisis in the marketplace: how food marketing contributes to childhood obesity and what can be done. , 2009, Annual review of public health.

[29]  E. Kraegen,et al.  Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat , 1997, Diabetes.

[30]  G. Hotamisligil Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. , 2005, Diabetes.

[31]  A. Prentice,et al.  Evolutionary origins of the obesity epidemic: natural selection of thrifty genes or genetic drift following predation release? , 2008, International Journal of Obesity.

[32]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[33]  X. Papademetris,et al.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[34]  L. N. Valenti,et al.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[35]  R. Shulman,et al.  Validation of 13c nmr measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples , 1992, Magnetic resonance in medicine.

[36]  Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. , 2002 .

[37]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[38]  R. Andres,et al.  Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. , 2005, Metabolism: clinical and experimental.

[39]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[40]  C. Bogardus,et al.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.

[41]  A. Newton,et al.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. , 2003, The Biochemical journal.

[42]  E. Kraegen,et al.  Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. , 1997, Diabetes.

[43]  Claudio Cobelli,et al.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men , 2006, Proceedings of the National Academy of Sciences.

[44]  Y. Miyazaki,et al.  Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. , 2004, The Journal of clinical endocrinology and metabolism.

[45]  G. Shulman,et al.  Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.

[46]  M. Gillum,et al.  Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.

[47]  K. Petersen,et al.  26 IMPAIRED MITOCHONDRIAL ACTIVITY IN INSULIN RESISTANT OFFSPRING OF TYPE 2 DIABETICS. , 2004, Journal of Investigative Medicine.

[48]  R. Hammer,et al.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.

[49]  N. Ruderman,et al.  Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .

[50]  G. Shulman,et al.  Contrasting Effects of IRS-1 Versus IRS-2 Gene Disruption on Carbohydrate and Lipid Metabolism in Vivo * , 2000, The Journal of Biological Chemistry.

[51]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[52]  S. Dufour,et al.  Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents , 2007, PloS one.

[53]  K. Siddle,et al.  Phorbol ester-induced downregulation of protein kinase C potentiates insulin receptor tyrosine autophosphorylation: evidence for a major constitutive role in insulin receptor regulation. , 1990, Biochemical Society transactions.

[54]  S. Watkins,et al.  Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.

[55]  D. James,et al.  Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. , 2010, Cell metabolism.

[56]  J. Horowitz,et al.  Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. , 2007, The Journal of clinical investigation.

[57]  K. Petersen,et al.  Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. , 2005, Diabetes.

[58]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[59]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[60]  G. Shulman,et al.  Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.

[61]  D. Chinkes,et al.  Intramuscular and liver triglycerides are increased in the elderly. , 2004, The Journal of clinical endocrinology and metabolism.

[62]  R. Shulman,et al.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[64]  C. Kahn,et al.  Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. , 1993, The Journal of clinical investigation.

[65]  F. Schick,et al.  Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: A dynamic 1H‐MRS study , 2001, Magnetic resonance in medicine.

[66]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[67]  L. Grummer-Strawn,et al.  Trends in state-specific prevalence of overweight and underweight in 2- through 4-year-old children from low-income families from 1989 through 2000. , 2004, Archives of pediatrics & adolescent medicine.

[68]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[69]  G. Shulman,et al.  PKC-theta knockout mice are protected from fat-induced insulin resistance. , 2004, The Journal of clinical investigation.

[70]  K. Petersen,et al.  Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients , 2007, Diabetes.

[71]  G. Boden Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[72]  C. Kahn,et al.  Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. , 1993, The Journal of clinical investigation.

[73]  H. Nakano,et al.  [Epidemiology of diabetes mellitus in the elderly]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[74]  K. Lindor,et al.  Nonalcoholic fatty liver disease , 2005, Canadian Medical Association Journal.

[75]  W. James,et al.  A life course approach to diet, nutrition and the prevention of chronic diseases , 2004, Public Health Nutrition.

[76]  G. Shulman,et al.  Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.

[77]  F. Schick,et al.  Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans , 2009, Diabetes Care.

[78]  A. Garg Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[79]  C. Kahn,et al.  Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. , 2001, The Journal of clinical investigation.

[80]  R. Eckel,et al.  Skeletal Muscle–Specific Deletion of Lipoprotein Lipase Enhances Insulin Signaling in Skeletal Muscle but Causes Insulin Resistance in Liver and Other Tissues , 2008, Diabetes.

[81]  K. Petersen,et al.  Altered Brain Mitochondrial Metabolism in Healthy Aging as Assessed by in vivo Magnetic Resonance Spectroscopy , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  B. Popkin,et al.  Overweight exceeds underweight among women in most developing countries. , 2005, The American journal of clinical nutrition.

[83]  N. Ruderman,et al.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.

[84]  Vincent Lebon,et al.  The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. , 2002, Diabetes.

[85]  B. S. Mohammed,et al.  Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.

[86]  K. Anderson,et al.  Epidemiology of diabetes mellitus in the elderly. The Framingham Study. , 1986, The American journal of medicine.

[87]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[88]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[89]  G. Shulman,et al.  Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle , 2008, Diabetes.

[90]  S. Mudaliar,et al.  Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. , 1995, The Journal of clinical investigation.

[91]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[92]  K. Petersen,et al.  Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. , 2001, The Journal of clinical investigation.

[93]  Jonathan Krakoff,et al.  Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.

[94]  M. Laakso,et al.  Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance , 2008, Cell.

[95]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[96]  Y. Miyazaki,et al.  Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. , 2002, American journal of physiology. Endocrinology and metabolism.

[97]  G. Marchesini,et al.  Obesity-associated liver disease. , 2008, The Journal of clinical endocrinology and metabolism.

[98]  B. Teusink,et al.  CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300143-JLR200 , 2003, Journal of Lipid Research.

[99]  Nick V. Grishin,et al.  A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.

[100]  R. Watson,et al.  GLUT4 translocation: the last 200 nanometers. , 2007, Cellular signalling.

[101]  M. Ridderstråle,et al.  A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans , 2009, Diabetologia.

[102]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[103]  J. Olefsky,et al.  Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.

[104]  A. Bonen,et al.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.

[105]  B. Kahn,et al.  Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. , 2005, American journal of physiology. Endocrinology and metabolism.

[106]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[107]  K. Petersen,et al.  Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. , 2005, The Journal of clinical investigation.

[108]  A. Baron,et al.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. , 1998, The Journal of clinical investigation.

[109]  G. Shulman,et al.  n-3 Fatty Acids Preserve Insulin Sensitivity In Vivo in a Peroxisome Proliferator–Activated Receptor-α–Dependent Manner , 2007, Diabetes.

[110]  S. Merali,et al.  Increase in Endoplasmic Reticulum Stress–Related Proteins and Genes in Adipose Tissue of Obese, Insulin-Resistant Individuals , 2008, Diabetes.

[111]  F. Schick,et al.  High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease , 2008, Gut.

[112]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[113]  S. Bandinelli,et al.  Diverse Effect of Inflammatory Markers on Insulin Resistance and Insulin‐Resistance Syndrome in the Elderly , 2004, Journal of the American Geriatrics Society.

[114]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[115]  D L Rothman,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13 C and 1 H Nuclear Magnetic Res , 1999 .

[116]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[117]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[118]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[119]  H. Joost,et al.  The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members , 2001, Molecular membrane biology.

[120]  Daniel R. Dries,et al.  A Single Residue in the C1 Domain Sensitizes Novel Protein Kinase C Isoforms to Cellular Diacylglycerol Production* , 2007, Journal of Biological Chemistry.

[121]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[122]  C. Kahn,et al.  Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. , 2000, The Journal of clinical investigation.

[123]  M. Czech,et al.  Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. , 1990, Biochemistry.

[124]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[125]  A. Häkkinen,et al.  Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. , 2004, Diabetes.

[126]  G. Shulman,et al.  n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. , 2007, Diabetes.

[127]  S. Lillioja,et al.  Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.

[128]  C. Cobelli,et al.  Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. , 2004, Diabetes.

[129]  G. Dohm,et al.  Increased protein kinase C theta in skeletal muscle of diabetic patients. , 2001, Metabolism: clinical and experimental.

[130]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[131]  R. Bergman,et al.  Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin , 1995, Diabetes.

[132]  Yiying Zhang,et al.  Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. , 2007, The Journal of clinical investigation.

[133]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[134]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[135]  K. Petersen,et al.  Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. , 2003, The Journal of clinical endocrinology and metabolism.

[136]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[137]  S. Wakil,et al.  Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity , 2007, Proceedings of the National Academy of Sciences.

[138]  G. Shulman,et al.  Metabolic Defects in Lean Nondiabetic Offspring of NIDDM Parents: A Cross-Sectional Study , 1997, Diabetes.

[139]  G. Shulman,et al.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[140]  E. Kraegen,et al.  Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle Phospholipid , 1991, Diabetes.

[141]  J. Olefsky,et al.  Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors. , 1991, The Journal of biological chemistry.

[142]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[143]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[144]  J. Olefsky,et al.  Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. , 1985, The Journal of clinical endocrinology and metabolism.

[145]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[146]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.